Though these medications are not intended as aesthetic treatments , their noticeable effects on body composition have made them a topic of discussion in the medical aesthetics community
Naunyn-Schmiedeberg's archives Pharmacol
Patients with non-alcoholic fatty liver disease may actually benefit from GLP-1 receptor agonists, as clinical studies show these medications can reduce liver fat content and improve liver enzyme levels
As the sector matures, the focus has apparently shifted from first-generation GLP-1 therapies toward differentiated approaches, including oral formulations, less frequent dosing schedules, improved body-composition outcomes such as lean muscle preservation, and next-generation mechanisms that combine GLP-1 with complementary pathways such as GIP, glucagon, and amylin
Considering that estimates suggest that more than 20 percent of the same population has some form of mental illness, it becomes clear that something is off-kilter in our brains and our bodies
Consumption of diets with low advanced glycation end products improves cardiometabolic parameters: meta-analysis of randomised controlled trials